Healthcare, biotechnology & medical AI Product
Qure.ai has separate clearances for qER and qER-CTA
Qure.ai’s qER flags specified suspected findings on noncontrast head CT. The separately cleared qER-CTA v1.0 sends alerts about a suspected large-vessel occlusion on eligible CT angiography images. [1][2]
What it does
The FDA cleared qER as K200921 in June 2020 and qER-CTA v1.0 as K251610 in September 2025. The submissions specify different input studies and findings. [1][2]
Why it matters
The distinction matters for reading a procurement or regulatory record: both products send triage alerts, and each addresses a different imaging workflow. [1][2]
Who it’s for
The filings address hospital networks and trained specialists reviewing or prioritizing head imaging. [1][2]
Key dates
Where it fits
qER alerts can flag possible bleeding, mass effect, midline shift or cranial fracture. The qER-CTA filing concerns specific arterial occlusions in adult CT angiography. [1][2]
Limits and trade-offs
The submissions describe notification and prioritization in parallel with the ordinary imaging workflow. Notifications and previews have an informational role. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for qER-CTA (v1.0) (K251610)
- Primary source FDA 510(k) decision for qER (K200921)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.